Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies (Q43658492)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies |
scientific article |
Statements
1 reference
Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies (English)
1 reference
1 reference
L L Siu
1 reference
J Nemunaitis
1 reference
J Rizzo
1 reference
L A Hammond
1 reference
C Takimoto
1 reference
S G Eckhardt
1 reference
A Tolcher
1 reference
C D Britten
1 reference
L Denis
1 reference
K Ferrante
1 reference
D D Von Hoff
1 reference
S Silberman
1 reference
E K Rowinsky
1 reference
1 July 2001
1 reference
1 reference
Identifiers
1 reference